RISS 학술연구정보서비스

검색

인기 검색어

    다국어 입력

    http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

    변환된 중국어를 복사하여 사용하시면 됩니다.

    예시)
    • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
    • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
    닫기
    KCI등재 SCOPUS

    Is Intratympanic Dexamathasone Injection Effectivefor the Treatment of Idiopathic SuddenSensorineural Hearing Loss?

    한글로보기

    https://www.riss.kr/link?id=A104761727

    • 0

      상세조회
    • 0

      다운로드
    서지정보 열기
    • 내보내기
    • 내책장담기
    • 공유하기
      • URL 복사
    • 오류접수
    인용문이 복사되었습니다.

    부가정보

    다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

    Background and Objectives: The purpose of this study is to identify the effectiveness of intratympanic (IT) steroids when used as an initial therapy in sudden sensorineural hearing loss (SSNHL), and when it is used as a salvage therapy in a refractory SSNHL.


    Subjects and Methods: This retrospective study included 122 patients with SSNHL. First, patients were divided into three groups according to the initial treatment; IT steroid, systemic steroid and combined (systemic and IT steroid) groups. Second, patients were divided into two groups according to the salvage treatment in a refractory SSNHL; IT steroid and the control (non IT group). Fifty eight patients who did not respond to initial therapy were included in the second analysis. Hearing was assessed immediately before the treatment and 2 weeks, 4 weeks and 3 months after the treatments. Hearing recovery was defined as an improvement of >15 dB and the final hearing of 25-45 dB in the audiogram.


    Results: When we analyzed the hearing recovery in initial treatment, the comparison of audiogram among three groups did not result in significantly different outcomes. There were no differences in the recovery rate in 2 and 4 weeks throughout all the frequencies. Also, the analysis of the salvage treatment demonstrated that neither IT steroid group nor control group was significantly effective in treating the refractory SSNHL.


    Conclusions: The results suggest that initial treatment of SSNHL with IT steroid alone is as effective as systemic steroid alone or a combination therapy. Also, salvage IT steroids for refractory SSNHL did not have any additional beneficial effects
    번역하기

    Background and Objectives: The purpose of this study is to identify the effectiveness of intratympanic (IT) steroids when used as an initial therapy in sudden sensorineural hearing loss (SSNHL), and when it is used as a salvage therapy in a refractor...

    Background and Objectives: The purpose of this study is to identify the effectiveness of intratympanic (IT) steroids when used as an initial therapy in sudden sensorineural hearing loss (SSNHL), and when it is used as a salvage therapy in a refractory SSNHL.


    Subjects and Methods: This retrospective study included 122 patients with SSNHL. First, patients were divided into three groups according to the initial treatment; IT steroid, systemic steroid and combined (systemic and IT steroid) groups. Second, patients were divided into two groups according to the salvage treatment in a refractory SSNHL; IT steroid and the control (non IT group). Fifty eight patients who did not respond to initial therapy were included in the second analysis. Hearing was assessed immediately before the treatment and 2 weeks, 4 weeks and 3 months after the treatments. Hearing recovery was defined as an improvement of >15 dB and the final hearing of 25-45 dB in the audiogram.


    Results: When we analyzed the hearing recovery in initial treatment, the comparison of audiogram among three groups did not result in significantly different outcomes. There were no differences in the recovery rate in 2 and 4 weeks throughout all the frequencies. Also, the analysis of the salvage treatment demonstrated that neither IT steroid group nor control group was significantly effective in treating the refractory SSNHL.


    Conclusions: The results suggest that initial treatment of SSNHL with IT steroid alone is as effective as systemic steroid alone or a combination therapy. Also, salvage IT steroids for refractory SSNHL did not have any additional beneficial effects

    더보기

    다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

    Background and Objectives: The purpose of this study is to identify the effectiveness of intratympanic (IT) steroids when used as an initial therapy in sudden sensorineural hearing loss (SSNHL), and when it is used as a salvage therapy in a refractory SSNHL.




    Subjects and Methods: This retrospective study included 122 patients with SSNHL. First, patients were divided into three groups according to the initial treatment; IT steroid, systemic steroid and combined (systemic and IT steroid) groups. Second, patients were divided into two groups according to the salvage treatment in a refractory SSNHL; IT steroid and the control (non IT group). Fifty eight patients who did not respond to initial therapy were included in the second analysis. Hearing was assessed immediately before the treatment and 2 weeks, 4 weeks and 3 months after the treatments. Hearing recovery was defined as an improvement of >15 dB and the final hearing of 25-45 dB in the audiogram.




    Results: When we analyzed the hearing recovery in initial treatment, the comparison of audiogram among three groups did not result in significantly different outcomes. There were no differences in the recovery rate in 2 and 4 weeks throughout all the frequencies. Also, the analysis of the salvage treatment demonstrated that neither IT steroid group nor control group was significantly effective in treating the refractory SSNHL.




    Conclusions: The results suggest that initial treatment of SSNHL with IT steroid alone is as effective as systemic steroid alone or a combination therapy. Also, salvage IT steroids for refractory SSNHL did not have any additional beneficial effects
    번역하기

    Background and Objectives: The purpose of this study is to identify the effectiveness of intratympanic (IT) steroids when used as an initial therapy in sudden sensorineural hearing loss (SSNHL), and when it is used as a salvage therapy in a refractor...

    Background and Objectives: The purpose of this study is to identify the effectiveness of intratympanic (IT) steroids when used as an initial therapy in sudden sensorineural hearing loss (SSNHL), and when it is used as a salvage therapy in a refractory SSNHL.




    Subjects and Methods: This retrospective study included 122 patients with SSNHL. First, patients were divided into three groups according to the initial treatment; IT steroid, systemic steroid and combined (systemic and IT steroid) groups. Second, patients were divided into two groups according to the salvage treatment in a refractory SSNHL; IT steroid and the control (non IT group). Fifty eight patients who did not respond to initial therapy were included in the second analysis. Hearing was assessed immediately before the treatment and 2 weeks, 4 weeks and 3 months after the treatments. Hearing recovery was defined as an improvement of >15 dB and the final hearing of 25-45 dB in the audiogram.




    Results: When we analyzed the hearing recovery in initial treatment, the comparison of audiogram among three groups did not result in significantly different outcomes. There were no differences in the recovery rate in 2 and 4 weeks throughout all the frequencies. Also, the analysis of the salvage treatment demonstrated that neither IT steroid group nor control group was significantly effective in treating the refractory SSNHL.




    Conclusions: The results suggest that initial treatment of SSNHL with IT steroid alone is as effective as systemic steroid alone or a combination therapy. Also, salvage IT steroids for refractory SSNHL did not have any additional beneficial effects

    더보기

    참고문헌 (Reference)

    1 Siegel LG, "The treatment of idiopathic sudden sensorineural hearing loss" 8 : 467-473, 1975

    2 Wilson WR, "The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study" 106 : 772-776, 1980

    3 Byl FM Jr, "Sudden hearing loss: eight years’ experience and suggested prognostic table" 94 (94): 647-661, 1984

    4 Moskowitz D, "Steroid use in idiopathic sudden sensorineural hearing loss" 94 (94): 664-666, 1984

    5 Rauch SD, "Intratympanic steroids for sensorineural hearing loss" 37 : 1061-1074, 2004

    6 Seggas I, "Intratympanic steroid therapy for sudden hearing loss: a review of the literature" 32 : 29-35, 2011

    7 Filipo R, "Intratympanic prednisolone therapy for sudden sensorineural hearing loss: a new protocol" 130 : 1209-1213, 2010

    8 Hargunani CA, "Intratympanic injection of dexamethasone: time course of inner ear distribution and conversion to its active form" 27 : 564-569, 2006

    9 Chandrasekhar SS, "Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation" 22 : 18-23, 2001

    10 Banerjee A, "Intratympanic corticosteroids for sudden idiopathic sensorineural hearing loss" 26 : 878-881, 2005

    1 Siegel LG, "The treatment of idiopathic sudden sensorineural hearing loss" 8 : 467-473, 1975

    2 Wilson WR, "The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study" 106 : 772-776, 1980

    3 Byl FM Jr, "Sudden hearing loss: eight years’ experience and suggested prognostic table" 94 (94): 647-661, 1984

    4 Moskowitz D, "Steroid use in idiopathic sudden sensorineural hearing loss" 94 (94): 664-666, 1984

    5 Rauch SD, "Intratympanic steroids for sensorineural hearing loss" 37 : 1061-1074, 2004

    6 Seggas I, "Intratympanic steroid therapy for sudden hearing loss: a review of the literature" 32 : 29-35, 2011

    7 Filipo R, "Intratympanic prednisolone therapy for sudden sensorineural hearing loss: a new protocol" 130 : 1209-1213, 2010

    8 Hargunani CA, "Intratympanic injection of dexamethasone: time course of inner ear distribution and conversion to its active form" 27 : 564-569, 2006

    9 Chandrasekhar SS, "Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation" 22 : 18-23, 2001

    10 Banerjee A, "Intratympanic corticosteroids for sudden idiopathic sensorineural hearing loss" 26 : 878-881, 2005

    11 Koltsidopoulos P, "Intratympanic and systemic steroids for sudden hearing loss" 34 : 771-776, 2013

    12 Bennett MH, "Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus" 10 : CD004739-, 2012

    13 Parnes LS, "Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application" 109 (109): 1-17, 1990

    14 Yee-Hyuk Kim, "Comparison of the Efficacy of Systemic and Combined Highly Frequent Intratympanic Steroid Treatment on Sudden Sensorineural Hearing Loss" 대한청각학회 15 (15): 133-136, 2011

    15 Yang CH, "Comparison of intratympanic steroid injection, hyperbaric oxygen and combination therapy in refractory sudden sensorineural hearing loss" 34 : 1411-1416, 2013

    16 Battaglia A, "Combination therapy (intratympanic dexamethasone+high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss" 29 : 453-460, 2008

    17 Stachler RJ, "Clinical practice guideline: sudden hearing loss" 146 (146): S1-S35, 2012

    18 Ahn JH, "Can intratympanic dexamethasone added to systemic steroids improve hearing outcome in patients with sudden deafness?" 118 : 279-282, 2008

    더보기

    동일학술지(권/호) 다른 논문

    동일학술지 더보기

    더보기

    분석정보

    View

    상세정보조회

    0

    Usage

    원문다운로드

    0

    대출신청

    0

    복사신청

    0

    EDDS신청

    0

    동일 주제 내 활용도 TOP

    더보기

    주제

    연도별 연구동향

    연도별 활용동향

    연관논문

    연구자 네트워크맵

    공동연구자 (7)

    유사연구자 (20) 활용도상위20명

    인용정보 인용지수 설명보기

    학술지 이력

    학술지 이력
    연월일 이력구분 이력상세 등재구분
    2023 평가 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
    2020-01-01 등재 등재학술지 유지 (해외등재 학술지 평가) KCI등재
    2015-05-22 학술지명변경 한글명 : korean journal of audiology -> Journal of Audiology & Otology KCI등재
    2013-10-01 등재 등재학술지 선정 (기타) KCI등재
    2011-01-01 등재 SCOPUS 등재 (기타) KCI등재후보
    더보기

    학술지 인용정보

    학술지 인용정보
    기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
    2016 0.19 0.19 0.13
    KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
    0.12 0.12 0.369 0
    더보기
    해외이동버튼